+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. In Vitro Fertilization Market Size, Share & Trends Analysis Report by Instrument (Disposable Devices, Capital Equipment) By Procedure Type (Fresh Donor, Frozen Donor) By End-use, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 70 Pages
  • May 2024
  • Region: United States
  • Grand View Research
  • ID: 5976487
Description Jump to:
The U.S. in vitro fertilization market size is anticipated to reach USD 7.24 billion by 2030, expanding at a CAGR of 4.4% from 2024 to 2030. The rising prevalence of infertility among couples, the continuous advancements in IVF technology and techniques, and the shift in societal norms and attitudes toward family have significantly contributed to the increasing demand for IVF services in the U.S.

The regulatory landscape surrounding assisted reproductive technologies, including IVF, also influences market dynamics. Regulations governing IVF practices, clinic accreditation standards, and ethical considerations impact the accessibility and quality of IVF services in the U.S. Changes in regulations can either facilitate or hinder market growth by affecting factors such as treatment costs, clinic operations, and patient safety.

Increased public awareness about infertility issues and available treatment options has played a crucial role in driving the growth of the U.S. IVF market. Educational campaigns, media coverage, and advocacy efforts have helped destigmatize infertility and promote understanding about fertility treatments like IVF. Greater awareness empowers individuals to make informed decisions about seeking fertility assistance through IVF.

U.S. In Vitro Fertilization Market Report Highlights

  • Based on instruments, the culture media segment dominated the market with around 40% share in 2023 owing to as availability of funding and an increase in research activities
  • The disposable devices segment is expected to grow at the fastest CAGR over the forecast period
  • Based on procedure type, the fresh non-donor segment held the largest market share of over 45% in 2023. Fresh cycles are often perceived as more cost-effective due to potentially requiring fewer treatment cycles to achieve a successful pregnancy
  • Frozen donors are expected to register the fastest CAGR during the forecast period owing to the convenience and flexibility offered by them
  • The fertility clinics segment dominated the market with around 80% share in 2023 and is expected to grow at the fastest CAGR over the forecast period
  • The increasing demand for ART treatments has led to a significant rise in the number of fertility clinics and ART centers
  • In October 2023, Merck & Co. announced the launch of Fertility benefit program with the aim to provide financial services to employees for fertility treatments. The range of services includes IVF treatments, fertility tests, and hormonal treatments

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Instrument
1.2.2. Procedure Type
1.2.3. End-use
1.2.4. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.2. Volume Price Analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Instrument Outlook
2.2.2. Procedure Type
2.2.3. End-use
2.3. Competitive Insights
Chapter 3. U.S. In Vitro Fertilization Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. U.S. In Vitro Fertilization Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape
Chapter 4. U.S. In Vitro Fertilization Market: Instrument Estimates & Trend Analysis
4.1. Instrument Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. In Vitro Fertilization Market by Instrument Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Disposable Media
4.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2. Culture Media
4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.2. Cryopreservation Media
4.4.2.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.3. Embryo Culture Media
4.4.2.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.4. Ovum Processing Media
4.4.2.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.5. Sperm Processing Media
4.4.2.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3. Capital Equipment
4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3.2. Sperm Analyzer Systems
4.4.3.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3.3. Imaging Systems
4.4.3.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3.4. Ovum Aspiration Pumps
4.4.3.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3.5. Micromanipulator Systems
4.4.3.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3.6. Incubators
4.4.3.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3.7. Gas Analyzers
4.4.3.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3.8. Laser Systems
4.4.3.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3.9. Cryosystems
4.4.3.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3.10. Sperm Separation Devices
4.4.3.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3.11. IVF Cabinets
4.4.3.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3.12. Anti-vibration Tables
4.4.3.12.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3.13. Witness Systems
4.4.3.13.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3.14. Other
4.4.3.14.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. In Vitro Fertilization Market: Procedure Type Estimates & Trend Analysis
5.1. Procedure Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. In Vitro Fertilization Market by Procedure Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Fresh Donor
5.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2. Frozen Donor
5.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.3. Fresh Non-donor
5.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.4. Frozen Non-donor
5.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. In Vitro Fertilization Market: End-use Estimates & Trend Analysis
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. In Vitro Fertilization Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Fertility Clinics
6.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. Hospitals & Others Setting
6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of Key Distributors and Channel Partners
7.3.2. Key Customers
7.3.3. Key Company Heat Map Analysis, 2023
7.4. Company Profiles
7.4.1. Bayer AG
7.4.1.1. Company Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Cook Medical LLC
7.4.2.1. Company Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. EMD Serono, Inc.
7.4.3.1. Company Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Ferring B.V.
7.4.4.1. Company Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
7.4.5.1. Company Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Genea Biomedx
7.4.6.1. Company Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. EMD Serono, Inc. (Merck KGaA)
7.4.7.1. Company Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Merck & Co., Inc.
7.4.8.1. Company Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. The Cooper Companies, Inc.
7.4.9.1. Company Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Thermo Fisher Scientific, Inc.
7.4.10.1. Company Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
7.4.11. Vitrolife
7.4.11.1. Company Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Strategic Initiatives
7.4.12. Nova IVF
7.4.12.1. Company Overview
7.4.12.2. Financial Performance
7.4.12.3. Product Benchmarking
7.4.12.4. Strategic Initiativesc
7.4.13. RMA Network (Reproductive Medicine Associates)
7.4.13.1. Company Overview
7.4.13.2. Financial Performance
7.4.13.3. Product Benchmarking
7.4.13.4. Strategic Initiatives
7.4.14. U.S. Fertility
7.4.14.1. Company Overview
7.4.14.2. Financial Performance
7.4.14.3. Product Benchmarking
7.4.14.4. Strategic Initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 U.S. In Vitro Fertilization Market, by Instrument, 2018-2030 (USD Million)
Table 3 U.S. In Vitro Fertilization Market, by Procedure Type, 2018-2030 (USD Million)
Table 4 U.S. In Vitro Fertilization Market, by End - Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value-chain-based Sizing & Forecasting
Figure 6 QFD Modeling for Market Share Assessment
Figure 7 Market Formulation & Validation
Figure 8 U.S. In Vitro Fertilization Market: Market Outlook
Figure 9 U.S. In Vitro Fertilization Competitive Insights
Figure 10 Parent Market Outlook
Figure 11 Related/ancillary Market Outlook
Figure 12 Penetration and Growth Prospect Mapping
Figure 13 U.S. In Vitro Fertilization Market Driver Impact
Figure 14 U.S. In Vitro Fertilization Market Restraint Impact
Figure 15 U.S. In Vitro Fertilization Market: Instrument Movement Analysis
Figure 16 U.S. In Vitro Fertilization Market: Instrument Outlook and Key Takeaways
Figure 17 Radiofrequency Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 18 Disposable Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 19 Culture Media Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 20 Cryopreservation Media Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 21 Embryo Culture Media Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 22 Ovum Processing Media Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 23 Sperm Processing Media Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 24 Capital Equipment Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 25 Sperm Analyzer Systems Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 26 Imaging Systems Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 27 Ovum Aspiration Pumps Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 28 Micromanipulator Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 29 Incubators Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 30 Gas Analyzers Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 31 Laser Systems Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 32 Cryosystems Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 Sperm Separation Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 34 IVF Cabinets Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 Anti - Vibration Tables Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 36 Witness Systems Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 37 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 38 U.S. In Vitro Fertilization Market: Procedure Type Movement Analysis
Figure 39 U.S. In Vitro Fertilization Market: Procedure Type Outlook and Key Takeaways
Figure 40 Surgical Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 Fresh Donor Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 42 Frozen Donor Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 43 Fresh Non - Donor Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 Frozen Non - Donor Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 U.S. In Vitro Fertilization Market: End - Use Outlook and Key Takeaways
Figure 46 Fertility Clinics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 Hospitals and Other Settings Market Estimates and Forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • Bayer AG
  • Cook Medical LLC
  • EMD Serono, Inc.
  • Ferring B.V.
  • FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
  • Genea Biomedx
  • EMD Serono, Inc. (Merck KGaA)
  • Merck & Co., Inc.
  • The Cooper Companies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Vitrolife
  • Nova IVF
  • RMA Network (Reproductive Medicine Associates)
  • U.S. Fertility

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages70
PublishedMay 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 5.28 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.24 Billion
Compound Annual Growth Rate4.4%
Regions CoveredUnited States
No. of Companies Mentioned14

Related Topics

Related Reports

In-Vitro Fertilization Market by Product, Types, Technology, Cycle Type, End User - Global Forecast 2025-2030 - Product Image

In-Vitro Fertilization Market by Product, Types, Technology, Cycle Type, End User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
In Vitro Fertilization Market Size, Share & Trends by Product (Equipment, Reagent, Accessories), Equipment (Imaging, Incubator, Microscope, Micromanipulator), Procedure (Conventional, ICSI, donor), Cycle (Fresh, Frozen), End-user (Hospital, Clinic) - Global Forecast to 2029 - Product Image

In Vitro Fertilization Market Size, Share & Trends by Product (Equipment, Reagent, Accessories), Equipment (Imaging, Incubator, Microscope, Micromanipulator), Procedure (Conventional, ICSI, donor), Cycle (Fresh, Frozen), End-user (Hospital, Clinic) - Global Forecast to 2029

  • Report
  • 281 Pages
  • Global
From
North America IVF (in-vitro fertilization) Market Outlook, 2029 - Product Image

North America IVF (in-vitro fertilization) Market Outlook, 2029

  • Report
  • 76 Pages
  • North America
From
IVF (in-vitro fertilization) Market Outlook, 2029 - Product Image

IVF (in-vitro fertilization) Market Outlook, 2029

  • Report
  • 173 Pages
  • Global
From
U.S. In-vitro Fertilization Microscope Market Size, Share & Trends Analysis Report by End-use (Clinical, Academic Research), and Segment Forecast, 2024-2030 - Product Image

U.S. In-vitro Fertilization Microscope Market Size, Share & Trends Analysis Report by End-use (Clinical, Academic Research), and Segment Forecast, 2024-2030

  • Report
  • 80 Pages
  • United States
From

About the In Vitro Fertilization Market

In Vitro Fertilization (IVF) is a medical procedure used to assist women in achieving pregnancy. It involves the fertilization of an egg outside of the body, in a laboratory setting. The egg is then transferred to the uterus, where it can implant and develop into a fetus. IVF is often used when other fertility treatments have failed, or when a woman has difficulty conceiving due to age, medical conditions, or other factors. It is also used for couples who are unable to conceive naturally due to male infertility. IVF has become an increasingly popular option for women seeking to become pregnant. It is a safe and effective procedure, with a high success rate. It is also a cost-effective option, as it can be used multiple times until a successful pregnancy is achieved. Some of the companies in the IVF market include OvaScience, CooperSurgical, and Ferring Pharmaceuticals. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.